News > Moderna’s boosted valuation has Tesla-like spin

Moderna’s boosted valuation has Tesla-like spin

Medical Buyer | 06/01/2022 08:22 AM | Click to read full article

There's the possibility of an mRNA influenza vaccine, which Chief Executive Stéphane Bancel hopes might be combined with the Covid shot. Drugmakers Pfizer and BioNTech said on 5 Jan, that they would develop a vaccine for shingles based on the mRNA technology used in their Covid-19 vaccine. Rival pharmaceutical firm Moderna also produced its Covid-19 vaccine using mRNA technology.